大型抑郁症治疗中GW117片的有效性和安全性:一项随机,双盲,安慰剂控制,第二阶段剂量确定研究
Yifeng Shen1, Xiaonan Hao2, Xiaoning Shi3
1Shanghai Mental Health Center, Shanghai, China.
General psychiatry
|December 22, 2025
概括
双重作用剂GW117在一小组主要抑郁症患者中显示出有前途的抗抑郁作用,特别是在失眠症状方面. 20mg剂量显示出统计学上显著的改善,具有良好的安全性,没有发现肝毒性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 临床医学 临床医学
背景情况:
- GW117是一种新型的双重作用药物 (MT1 / MT2激动剂,5-HT2C对抗剂),具有潜在的抗抑郁药特性.
- 以前的研究表明,GW117的有效性和安全性是有利的.
研究的目的:
- 评估GW117在患有严重抑郁症 (MDD) 患者的疗效和安全性.
- 为了确定GW117在MDD治疗中的最佳剂量方案.
主要方法:
- 一项随机,双盲,安慰剂对照试验,涉及280名年龄在18-65岁之间的MDD患者.
- 患者接受了固定剂量的GW117 (20,40,60毫克/天) 或安慰剂8周.
- 主要终点:HAMD-17分数的变化;次要终点:MADRS分数的变化.
主要成果:
- 与安慰剂相比,GW117在HAMD-17和MADRS得分上表现出数量上更大的减少,但在总人口中没有达到统计学意义.
- 后期分析显示,GW117 20mg在一个最佳子组 (HAMD-17>24或失眠因子>4) 中显著改善了包括失眠在内的多维症状.
- GW117的耐受性很好,没有报告的肝毒性或安全问题.
结论:
- 在MDD患者中,GW117表现出令人鼓舞的抗抑郁药疗效和有利的安全性.
- 20毫克的剂量在特定的患者亚组中显示出显著的益处,特别是对于失眠相关的症状.
- 由于其有前途的治疗潜力,GW117的进一步临床开发是有必要的.
更多相关视频
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
770
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
770
Bioavailability Study Design: Healthy Subjects Versus Patients
133
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
133
The Placebo Effect
6.8K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.8K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Antidepressant Drugs: Overview
1.3K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.3K
Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K


